15
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10510 |
CB1 antagonist 1
|
Cannabinoid Receptor | GPCR/G Protein |
CB1 antagonist 1 is a CB1 receptor antagonist, used in the research of obesity and metabolic syndrome, neuroinflammatory disorders, cognitive disorders, and gastrointestinal disorders, psychosis, and cardiovascular. | |||
T14881 |
CB1 antagonist 2
AM4113 |
Cannabinoid Receptor | GPCR/G Protein |
CB1 antagonist 2 (AM4113) 是一种 caimabinoid 1 拮抗剂,在体内抑制 CB1 的IC50值为 25.5 nM。 | |||
T5996 |
CB1-IN-1
DBPR211,1-(2,4-二氯苯基)-N-1-哌啶基-4-[[(1-吡咯烷基磺酰基)氨基]甲基]-5-[5-[2-[4-(三氟甲基)苯基]乙炔基]-2-噻吩基]-1H-吡唑-3-甲酰胺 |
Cannabinoid Receptor | GPCR/G Protein |
CB1-IN-1 (DBPR211) 是新型的外周大麻素-1受体 (CB1R) 拮抗剂,作用于CB1R (EC50 = 3 nM) 和 CB2R 的Ki 分别为0.3 nM 和 21 nM。 | |||
T41350 |
6-Bromopravadoline
WIN 54461 |
Cannabinoid Receptor | GPCR/G Protein |
6-Bromopravadoline (WIN 54461) (WIN 54461) 是CB1受体的拮抗剂。6-Bromopravadoline 作为 [3H]Win 55212-2 的结合抑制剂 (IC50=515 nM),反映了其与大麻素受体结合。 | |||
T1519 |
Rimonabant hydrochloride
盐酸利莫那班,SR 151716A,SR 141716A |
Cannabinoid Receptor; Antibacterial | GPCR/G Protein; Microbiology/Virology |
Rimonabant hydrochloride (SR 141716A) 是中心大麻素受体 1 的高效选择性反向激动剂, Ki 值为1.8 nM。它也能够抑制分枝杆菌膜蛋白3。 | |||
T8511 |
TM38837
|
Cannabinoid Receptor | GPCR/G Protein |
TM38837 是外周选择性大麻素受体1型受体拮抗剂。它减少精神病副作用的倾向。它对大脑的渗透率有限,以降低或防止 CNS 不良反应,并保留潜在的抗肥胖作用。 | |||
T1915 |
AM251
|
Cannabinoid Receptor; GPR | Endocrinology/Hormones; GPCR/G Protein |
AM251 是一种选择性大麻素1 受体拮抗剂,IC50=8 nM,是一种 GPR55 的激动剂,EC50=39 nM。 | |||
T13081 |
Taranabant racemate
MK-0364 racemate |
Cannabinoid Receptor | GPCR/G Protein |
Taranabant racemate is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor. | |||
T83533 |
(R)-Monlunabant
(R)-MRI-1891 |
Cannabinoid Receptor | GPCR/G Protein |
(R)-Monlunabant ((R)-MRI-1891)为CB1受体调节剂,应用于肥胖及代谢病研究领域。 | |||
T22140 |
(R)-SLV 319
|
||
(R)-SLV 319 是一种有效的、选择性的大麻素受体 1 (CB1)拮抗剂,Ki 值为 894 nM。(R)-SLV 319 是 SLV 319 的右旋对映体。 | |||
T78674 |
Isopropyl dodec-11-enylfluorophosphonate
IDEFP |
FAAH | Metabolism; Neuroscience |
Isopropyl dodec-11-enylfluorophosphonate (IDEFP) 为有机磷酯类化合物,能抑制中枢大麻素受体 (cannabinoid receptor) (CB1) 并具有相似的效力抑制FAAH(IC50s = 2 nM)。 | |||
T21914 |
(S)-SLV 319
|
||
Ibipinabant (SLV319) 是一种有效,选择性和具有口服活性的大麻素 CB1 受体 (cannabinoid CB1 receptor) 的拮抗剂,Ki 值为 7.8 nM。Ibipinabant 对 CB1 的选择性超过 CB2 (Ki=7943 nM) 的 1000 倍以上。Ibipinabant 可用于肥胖和糖尿病的研究。 | |||
T36591 |
ABD459
|
||
ABD459 is a neutral antagonist of the central cannabinoid 1 (CB1) receptor (Ki = 8.6 nM). It inhibits food consumption in nonfasted mice without affecting motor activity. ABD459 reduces active food seeking for 5-6 hours after treatment, with no rebound after washout. ABD459 also diminishes rapid eye movement (REM) sleep, with no alterations of wakefulness or non-REM sleep. | |||
T21811 |
LH 21
|
||
LH-21 是一种有效的体内中性大麻素 CB1受体拮抗剂。LH-21 会导致剂量依赖性进食抑制,减少肥胖 Zucker 大鼠的食物摄入和体重增加。 | |||
T23099 |
O-2050
|
Others | Others |
O-2050 是一种高亲和力的大麻素CB1受体拮抗剂,Ki 为 2.5 nM。O-2050 抑制大麻素 CB2受体,Ki 为 0.2 nM。O-2050 减少了小鼠的食物摄入量,并且引起小鼠运动。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN5131 |
Tetrahydrocannabivarin
THCV,delta9-Tetrahydrocannabivarin,CRM,Tetrahydrocannavarin |
Cannabinoid Receptor | GPCR/G Protein |
Tetrahydrocannabivarin (CRM) 是 cannabinoid type 1 receptor 的中性拮抗剂,对 2 型糖尿病有潜在治疗价值。 |